Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries-Reference-Cited by-同舟云学术

Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

Published:2017-07-24 Issue:9 Volume:49 Page:1408-1413
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Boeva Valentina^ORCID,Louis-Brennetot Caroline,Peltier Agathe,Durand Simon,Pierre-Eugène Cécile,Raynal Virginie,Etchevers Heather C^ORCID,Thomas Sophie,Lermine Alban,Daudigeos-Dubus Estelle,Geoerger Birgit,Orth Martin F,Grünewald Thomas G P,Diaz Elise,Ducos Bertrand,Surdez Didier^ORCID,Carcaboso Angel M^ORCID,Medvedeva Irina,Deller Thomas,Combaret Valérie,Lapouble Eve,Pierron Gaelle^ORCID,Grossetête-Lalami Sandrine,Baulande Sylvain,Schleiermacher Gudrun^ORCID,Barillot Emmanuel^ORCID,Rohrer Hermann,Delattre Olivier,Janoueix-Lerosey Isabelle^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3921.pdf

Reference44 articles.

1. Matthay, K.K. et al. Neuroblastoma. Nat. Rev. Dis. Primers 2, 16078 (2016).

2. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. & Bishop, J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121–1124 (1984).

3. Mossé, Y.P. et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455, 930–935 (2008).

4. Janoueix-Lerosey, I. et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455, 967–970 (2008).

5. George, R.E. et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 455, 975–978 (2008).

Cited by 348 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell state plasticity in neuroblastoma;EJC Paediatric Oncology;2024-12

2. Intercellular extrachromosomal DNA copy-number heterogeneity drives neuroblastoma cell state diversity;Cell Reports;2024-09

3. Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticity;The EMBO Journal;2024-08-22

4. Transcription factor 4 is a key mediator of oncogenesis in neuroblastoma by promoting MYC activity;Molecular Oncology;2024-08-09

5. Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures;Cancer Research Communications;2024-08-01